The world’s first malaria vaccine is showing results beyond clinical trials.
A new study in The Lancet Global Health followed nearly 40,000 children in Ghana, Kenya and Malawi after the RTS,S vaccine was introduced into routine immunization programs.
Researchers found that vaccinated children had lower rates of malaria, severe malaria and malaria-related hospitalizations.
The findings add to growing evidence that malaria vaccination can help protect children in regions where the disease remains a major threat.
Read the study: http://spkl.io/60497bn27